GlobeNewswire Inc. · Mar 6, 2025
Advanced Biomed Inc. Announces Pricing of Initial Public Offering
Advanced Biomed Inc., a biotechnology company focused on cancer diagnostics and treatment, has announced the pricing of its initial public offering on the Nasdaq Capital Market. The company expects to raise $6.56 million from the offering, which will be used for research, development, and expansion.

